18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Designed to evaluate dose response of force-titrated prandial administration of TI as
compared to placebo (TP) in subjects with Type 2 diabetes who were suboptimally controlled